JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 15,210
+220 (1.47%)
At close: Nov 17, 2025
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 235.37 billion as of November 26, 2025. Its market cap has increased by 39.71% in one year.
Market Cap
235.37B
Enterprise Value
258.42B
Revenue
248.30B
Ranking
n/a
PE Ratio
4.94
Stock Price
15,210.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 235.37B, a decrease of -30.78%. That is a compound annual growth rate of -3.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 225.30B | 33.73% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | 328.57B | 4.80% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |